We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-1.29%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$664M
AUM Growth
-$538M
Cap. Flow
-$484M
Cap. Flow %
-72.87%
Top 10 Hldgs %
25.32%
Holding
142
New
15
Increased
24
Reduced
58
Closed
34

Sector Composition

Rank Sector Weight
1 Healthcare 95.16%
2 Industrials 3.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ELV icon
76
Elevance Health
ELV
$81.5B
$2.61M 0.39%
+5,625
New +$2.37M
TNDM icon
77
Tandem Diabetes Care
TNDM
$1.34B
$2.37M 0.36%
15,775
+2,025
+15% +$273K
SYK icon
78
Stryker
SYK
$125B
$2.3M 0.35%
8,600
-600
-7% -$157K
HUM icon
79
Humana
HUM
$43.7B
$2.27M 0.34%
+4,900
New +$2.17M
REGN icon
80
Regeneron Pharmaceuticals
REGN
$78.5B
$2.15M 0.32%
3,410
-310
-8% -$191K
PROC
81
DELISTED
Procaps Group, S.A. Ordinary Shares
PROC
$2.14M 0.32%
219,244
-55,031
-20% -$537K
TDOC icon
82
Teladoc Health
TDOC
$1.22B
$2.09M 0.31%
22,750
-30,388
-57% -$3.63M
SONX
83
DELISTED
Sonendo, Inc.
SONX
$1.99M 0.3%
+345,017
New +$3.1M
DOCS icon
84
Doximity
DOCS
$3.76B
$1.94M 0.29%
+38,750
New +$2.52M
BBLN
85
DELISTED
Babylon Holdings Limited
BBLN
$1.85M 0.28%
+12,724
New +$2.71M
VRTX icon
86
Vertex Pharmaceuticals
VRTX
$121B
$1.71M 0.26%
7,771
-1,950
-20% -$379K
GILD icon
87
Gilead Sciences
GILD
$162B
$1.66M 0.25%
22,900
-6,350
-22% -$437K
CMPI
88
DELISTED
Checkmate Pharmaceuticals, Inc. Common Stock
CMPI
$1.55M 0.23%
541,766
ILMN icon
89
Illumina
ILMN
$31B
$1.51M 0.23%
4,071
EW icon
90
Edwards Lifesciences
EW
$49.6B
$1.43M 0.21%
+11,000
New +$1.28M
ONC
91
BeOne Medicines Ltd
ONC
$32.8B
$1.29M 0.19%
4,780
-1,220
-20% -$412K
ALNY icon
92
Alnylam Pharmaceuticals
ALNY
$27.5B
$1.29M 0.19%
7,596
-68,250
-90% -$12.7M
BMRN icon
93
BioMarin Pharmaceuticals
BMRN
$11.6B
$895K 0.13%
10,130
-95,982
-90% -$7.92M
ASND icon
94
Ascendis Pharma A/S
ASND
$16B
$825K 0.12%
6,129
-32,521
-84% -$4.84M
BNTX icon
95
BioNTech
BNTX
$22.9B
$762K 0.11%
2,955
+1,855
+169% +$508K
ICLR icon
96
Icon
ICLR
$12.6B
$681K 0.1%
2,200
-44,650
-95% -$12.5M
A icon
97
Agilent Technologies
A
$39.1B
$655K 0.1%
4,100
-115,000
-97% -$17.9M
ZLAB icon
98
Zai Lab
ZLAB
$2.06B
$566K 0.09%
9,000
+3,100
+53% +$263K
GH icon
99
Guardant Health
GH
$21.7B
$477K 0.07%
4,770
-60,616
-93% -$6.27M
STVN icon
100
Stevanato
STVN
$5.42B
$441K 0.07%
19,643
-193,070
-91% -$4.58M

Similar funds

Sectoral Asset Management's Q4 2021 Portfolio in Review

As of Q4 2021, Sectoral Asset Management held 142 positions worth $664M, down 45% from $1.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Sectoral Asset Management withdrew a net $484M in Q4 2021, closing 34 positions and reducing 58 holdings. Its most notable exit was ResMed, an estimated $15.8M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 95% a quarter earlier, followed by Industrials.

Against the trend, Sectoral Asset Management opened a new position in Certara worth $9.96M.

  • Sectoral Asset Management's largest Q4 2021 buy was Certara: 350,438 shares worth $9.96M.
  • Sectoral Asset Management added most to Mirati Therapeutics, Inc. Common Stock in Q4 2021, an estimated $11.4M increase.
  • Sectoral Asset Management's biggest Q4 2021 reduction was Agilent Technologies, cutting an estimated $17.9M.
  • Sectoral Asset Management fully exited ResMed in Q4 2021, selling an estimated $15.8M.
  • Sectoral Asset Management's ten largest holdings make up 25% of its $664M portfolio in Q4 2021.
  • Sectoral Asset Management opened 15 new positions and closed 34 in Q4 2021.
  • Sectoral Asset Management's portfolio value fell 45% quarter-over-quarter to $664M.

Based on Sectoral Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.